Public Consultation on the Post-market Review of the Life Saving Drugs Programme (LSDP)

Page last updated: 12 March 2015

Public Submissions: 11 August 2014 to 10 November 2014

The Call for Submissions addressing the Life Saving Drugs Programme (LSDP) closed on 10 November 2014. The Department appreciates the contribution of all organisations and individuals who made a submission.

Disclaimer

  • The views expressed in submissions published on this website are solely those of the contributing authors or organisations.
  • The Commonwealth accepts no responsibility for the completeness or accuracy of any information contained in the submissions.
  • The Commonwealth makes no representations about the suitability of the information for any particular purpose. Users of the information must make their own inquires and assessments about those matters or seek independent advice.
  • Submissions are published on the understanding that the contributing authors or organisations have copyright in the submissions either by way of ownership or a licence. They retain their copyright, and by making submissions they licence the Commonwealth to publish the submissions, unless a party when making a submission has requested that it be kept confidential and the Commonwealth clearly agrees that the submission will be kept confidential.

Subscribe to news updates for the latest information regarding reviews, including public consultation opportunities.

Privacy

Unless otherwise requested, submissions addressing the Post-market Review of the Life Saving Drugs Programme (LSDP) have been published below.

The Department of Health does not publish submissions, or parts of submissions, which contain personal information, offensive language, potentially defamatory material or copyright infringing material.

Responsibility for copyright in submissions resides with the author(s), not with the Department of Health.

All submissions have been converted to Portable Document Format (PDF) for publication and may have a different appearance to the document that was submitted.

Your submission and contact details will be stored in accordance with the Australian Privacy Principles from Schedule 1 of the Privacy Amendment (Enhancing Privacy Principles) Act 2012 and the Archives Act 2012.  Should you have any concerns about the storage of your submission, or if you wish to gain access to make a correction, please contact the PBS Post-Market. A copy of the Department’s privacy policy is available on request. If you wish to make a complaint about the handling of your private information, you may contact the Department of Health Privacy Contact Officer on 02 6289 5773 and, if unsatisfied with the response, you may submit a complaint to the Office of the Australian Information Commissioner.

Table of Submissions

Table of Submissions
Submission Author Name Document Link Date Received
1 Health Professional Not for publication 23/09/2014
2 Dr James Gray Submission 2 (PDF 53KB) 05/10/2014
3 Consumer Submission 3 (PDF 106KB) 24/10/2014
4 Professor Jeffrey Szer Submission 4 (PDF 357KB) 26/10/2014
5 Clinical Professor Jack Goldblatt Submission 5 (PDF 63KB) 28/10/2014
6 Duchenne Foundation Submission 6 (PDF 2.9MB) 04/11/2014
7 Australian Pompe’s Association Submission 7 (PDF 3.6MB) 05/11/2014
8 Fabry Support Group Australia Submission 8 (PDF 268KB) 07/11/2014
9 BioMarin Pharmaceutical Australia Submission  9 (PDF 163KB) 07/11/2014
10 Dr David Ketteridge Submission 10 (PDF 1.7MB) 07/11/2014
11 Gaucher Association of Australia Not for publication 07/11/2014
12 Pfizer Australia Submission 12 (PDF 2.5MB) 09/11/2014
13 Carer Submission 13 (PDF 47KB) 09/11/2014
14 Carer Submission 14 (PDF 4.7MB) 09/11/2014
15 AstraZeneca Submission 15 (PDF 92KB) 09/11/2014
16 uniQure Biopharma B.V. Submission 16 (PDF 4MB) 10/11/2014
17 Shire Australia Submission 17 (PDF 171KB) 10/11/2014
18 Non-Government Organisation Not for publication 10/11/2014
19 Vertex Pharmaceuticals Submission 19 (PDF 516KB) 10/11/2014
20 Rare Voices Australia Submission 20 (PDF 525KB) 10/11/2014
21 Office of Population Health Genomics and Genetic Services (WA Department of Health) Submission 21 (PDF 187KB) 10/11/2014
22 Consumer Not for publication 10/11/2014
23 The McKell Institute Submission 23 (PDF 1.6MB) 10/11/2014
24 Medicines Australia Submission 24 (PDF 4.9MB) 10/11/2014
25 The Cancer Drugs Alliance Submission 25 (PDF 169KB) 10/11/2014
26 Mucopolysaccharide & Related Diseases Society Australia Ltd Submission 26 (PDF 211KB) 10/11/2014
27 Genzyme, A Sanofi Company Not for publication 10/11/2014
28 Australasian Society of Inborn Errors of Metabolism Submission 28 (PDF 770KB) 10/11/2014
29 GlaxoSmithKline Submission 29 (PDF 115KB) 10/11/2014
30 Alexion Pharmaceuticals Australasia Not for publication 11/11/2014
31 The Society of Hospital Pharmacists Australia Submission 31 (PDF 115KB) 14/11/2014